Tissue plasminogen activator and Staphylococcus epidermidis endophthalmitis

Area of Science:

• Ophthalmology
• Microbiology

Background:

• Endophthalmitis is an intraocular infection causing inflammation and potential vision loss.
• Fibroproliferative complications can arise from severe ocular inflammation.
• Tissue plasminogen activator (tPA) is a fibrinolytic agent with potential therapeutic applications.

Purpose of the Study:

• To evaluate the efficacy of intraocular tissue plasminogen activator (tPA) in managing experimental endophthalmitis.
• To determine if tPA accelerates inflammatory debris clearance.
• To assess tPA's ability to prevent fibroproliferative complications in a rabbit model.

Main Methods:

• Aphakic rabbits were inoculated with Staphylococcus epidermidis to induce moderate endophthalmitis.
• Rabbits received intraocular injections of either tPA or saline on days 2 and 3 post-inoculation.
• Ocular inflammation was assessed by a masked clinician over 28 days, with vitreous cultures performed.

Main Results:

• No significant difference in inflammatory scores was observed between tPA-treated and control eyes.
• Eyes treated with tPA showed a trend towards more retinal detachments and positive cultures, but this was not statistically significant.
• Intraocular tPA did not demonstrate a clear benefit in reducing inflammation or preventing complications.

Conclusions:

• Intraocular fibrinolysis using tPA does not accelerate inflammation clearance in this endophthalmitis model.
• tPA administration did not decrease fibroproliferative complications in the studied animal model.
• The findings suggest that intraocular tPA is not effective for treating experimental endophthalmitis.